Trident Texofab

Trident_Texofab06 May 2024

Trading

₹

+1.31 (+2.76%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Trident Texofab

Trident Texofab

Trading

Trident_Texofab06 May 2024

₹

+1.31 (+2.76%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
29-May-2019	D	The board of director of the company has approved and recommend final dividend for the Financial Year 2018-19 @10% i.e. Rs. 1.00/- (Rupee One only) per equity share of Rs. 10/- (Rupees Ten only) each and @05% i.e. Rs. 0.50/- (Rupee fifty paisa only) per Compulsorily Convertible Preference Shares (CCPS) of Rs. 10/- (Rupees Ten only) and the same shall be payable subject to approval of the shareholders at the ensuing Annual General Meeting of the Company within prescribed time limit. The above said meeting of the board commenced at 04.30 p.m. and concluded at 07.40 p.m.	18-Jul-2019
26-May-2018	D	Trident Texofab Ltd has submitted that the board at its meeting held on today i.e. 28.05.2018 recommend final dividend of Rs. 1.00/- (10%) per equity share of the face value of Rs. 10/- each for the financial year ended on 31st March, 2018 subject to approval of the same by the members in ensuing Annual General Meeting and record date for payment of dividend shall be 03.07.2018. This is to inform you that the final dividend declared in 101h Annual General Meeting of the Company held on 10th July, 2018 will be paid on 26th July, 2018. (As Per BSE Announcement Dated on 18.07.2018)	02-Jul-2018
04-Aug-2020	B	Trading Members of the Exchange are hereby informed that, Trident Texofab Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Trident Texofab Limited (540726) RECORD DATE 12/08/2020 PURPOSE Issue of 14 (Fourteen) Bonus equity shares of Rs.10/- each for every 10 (Ten) existing equity shares of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 11/08/2020 DR-091/2020-2021 Trading Members are requested to note the change in the market lot of Trident Texofab Limited (540726) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, August 11, 2020: Scrip Code 540726 Scrip Name Trident Texofab Limited Current Market Lot 1000 Revised Market Lot 2400	12-Aug-2020	14:10
23-Mar-2024	BC	The Board of Directors of the company has approved the Alteration of Memorandum and Article of Association, subject to approval of members of the company. Notice of Postal Ballot (As Per BSE A	26-Apr-2024
28-Mar-2024	BC	Trident Lifeline Limited	27-Mar-2024
27-Mar-2024	BC	Hardik Desai Family Trust	26-Mar-2024
23-Mar-2024	BC	The Board of Directors of the company has approved the Alteration of Memorandum and Article of Association, subject to approval of members of the company. The Board of Directors of the company ha	23-Mar-2024
05-Mar-2024	BC	Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/03/2024 inter alia to consider and approve including:- 1. To Review the performanc	13-Mar-2024

No Rights has been declared by Trident_Texofab

Book Closure

Record Date	Split Date	Purpose
26-Apr-2024	01 Jan'1900	The Board of Directors of the company has approved the Alteration of Memorandum and Article of Association, subject to approval of members of the company. Notice of Postal Ballot (As Per BSE A
27-Mar-2024	-	Trident Lifeline Limited
26-Mar-2024	-	Hardik Desai Family Trust
23-Mar-2024	-	The Board of Directors of the company has approved the Alteration of Memorandum and Article of Association, subject to approval of members of the company. The Board of Directors of the company ha
13-Mar-2024	-	Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/03/2024 inter alia to consider and approve including:- 1. To Review the performanc

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Trident Texofab Ltd ₹48.85(+1.31/2.76%)	48.85	+1.31	47.87	-27.36	36.02	3.03
Computer Point Ltd ₹5.20(+0.11/2.16%)	5.20	+0.11	15.27	116.60	0.00	0.46
Ambalal Sarabhai Enterprises Ltd ₹45.00(-0.47/-1.03%)	45.00	-0.47	348.45	102.27	0.00	9.57
Novartis India Ltd ₹1,052.00(-5.25/-0.50%)	1,052.00	-5.25	2,610.43	77.90	27.33	3.72
Aegis Logistics Ltd ₹609.15(-20.15/-3.20%)	609.15	-20.15	22,088.43	60.91	50.06	9.95
Mysore Petro Chemicals Ltd ₹180.25(-3.65/-1.98%)	180.25	-3.65	121.07	59.98	16.22	1.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	23.01	23.20	23.10	24.24	24.55	24.17
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	23.01	23.20	23.10	24.24	24.55	24.17
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.11	1.03	-0.25	0.89	0.74	0.14
Total Income	23.12	24.23	22.85	25.13	25.29	24.31
Total Expenditure	21.11	21.94	21.70	23.79	22.44	22.01
PBIDT	2.00	2.29	1.15	1.34	2.85	2.29
Interest	0.93	1.07	0.91	1.09	0.92	0.84
PBDT	1.08	1.22	0.24	0.25	1.93	1.45
Depreciation	0.41	0.41	0.41	0.41	0.40	0.42
Tax	0.06	0.00	0.00	-0.26	0.15	0.19
Deferred Tax	0.05	0.06	-0.04	0.05	0.24	0.06
Reported Profit After Tax	0.56	0.75	-0.13	0.06	1.15	0.78
Extra-ordinary Items	0.00	0.00	-0.03	-0.06	-0.04	0.00
Adjusted Profit After Extra-ordinary item	0.56	0.75	-0.10	0.12	1.19	0.78

EPS (Unit Curr.)	0.55	0.75	-0.13	0.06	1.14	0.77
EPS (Adj) (Unit Curr.)	0.55	0.75	-0.13	0.06	1.14	0.77
Calculated EPS (Unit Curr.)	0.55	0.75	-0.13	0.06	1.14	0.77
Calculated EPS (Adj) (Unit Curr.)	0.55	0.75	-0.13	0.06	1.14	0.77
Calculated EPS (Ann.) (Unit Curr.)	2.22	2.99	-0.51	0.22	4.57	3.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)	2.22	2.99	-0.51	0.22	4.57	3.09
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.07	10.07	10.07	10.07	10.07	10.07
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.69	9.87	4.98	5.53	11.61	9.47
PBDTM(%)	4.69	5.26	1.04	1.03	7.86	6.00
PATM(%)	2.43	3.23	-0.56	0.25	4.68	3.23

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.07	10.07	10.07	4.20	4.20	4.00
Reserves Total	5.11	2.89	1.91	7.43	6.80	4.27
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	15.18	12.96	11.98	11.63	11.00	8.27
Secured Loans	28.10	30.91	24.44	16.16	9.51	3.10
Unsecured Loans	9.67	7.97	9.58	6.08	5.41	1.93
Total Debt	37.77	38.88	34.02	22.24	14.92	5.03
Total Liabilities	52.95	51.84	46.00	33.87	25.92	13.30
APPLICATION OF FUNDS :
Gross Block	28.56	25.43	16.75	14.18	3.27	2.17
Less : Accumulated Depreciation	5.23	3.72	2.54	1.70	0.91	0.61
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	23.33	21.71	14.21	12.48	2.36	1.56
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	3.62	8.89	0.30	6.39	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.64	2.06	2.48	1.12	1.42	2.65
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	10.64	7.27	8.01	10.11	3.93	5.07
Sundry Debtors	33.87	30.85	30.28	26.43	29.40	32.13
Cash and Bank	0.06	0.04	0.03	0.08	0.39	0.23
Loans and Advances	2.11	1.86	1.68	3.31	2.37	2.80
Total Current Assets	46.69	40.03	40.00	39.94	36.08	40.23
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	18.91	12.71	17.28	17.09	19.89	30.73
Provisions	2.01	1.82	1.09	0.48	1.23	0.89
Total Current Liabilities	20.92	14.53	18.38	17.57	21.12	31.62
Net Current Assets	25.77	25.49	21.62	22.37	14.96	8.61
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.38	0.97	0.68	0.31	0.01	0.02
Net Deferred Tax	-1.38	-0.97	-0.68	-0.31	-0.01	-0.02
Total Assets	51.36	51.91	46.53	35.96	25.12	12.80
Contingent Liabilities	1.44	1.44	1.44	1.44	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.04	0.03	0.08	0.39	0.17
Net Cash from Operating Activities	5.85	1.39	1.96	-2.85	-2.75
Net Cash Used In Investing Activities	0.37	-4.38	-10.19	-2.41	-6.61
Net Cash Used In Financing Activities	-6.20	2.99	8.19	4.95	9.59
Net Inc./Dec In Cash And Cash Equivalents	0.02	0.00	-0.05	-0.31	0.22
Cash And Cash Equivalents At End Of The Year	0.06	0.04	0.03	0.08	0.39

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

61.74%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

38.26%

**Promoter pledged shareholding 61.74%

About Trident Texofab Ltd

Trident Texofab Ltd is in the Trading sector, having a market capitalization of Rs. 47.87 crores. It has reported a sales of Rs. 23.01 crores and a net profit of Rs. 0.56 crores for the quarter ended December 2018. The company management includes Hardik J Desai, Hardik J Desai,Chetan C Jariwala,Natasha F Dsouza,Ankita Jignesh Saraiya,Deepak P Gandhi,Vrusti B Patel,Manish Dhirajlaa Halwawala,Rushi Hemantkumar Jagani,Mishal Shailesh Patel (Trident Texofab Ltd) among others.

Chairman

Hardik J Desai

Registered office

2004 2nd Flr North Extension,Nodh 4/1650 Sahara Darwaja,Surat,Gujarat,395003

FAX :

Background

Incorporation Year2008

Face Value₹10

Market Lot1

How to buy Trident Texofab shares on nse?

To buy Trident Texofab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Trident Texofab share price today?

The Trident Texofab shares price on nse is Rs.48.85 today.

What is the market cap of Trident Texofab shares on BSE ?

The company has a market capitalization of Rs.47.87Cr

What is the PE & PB ratio of Trident Texofab shares ?

PE is 36.02 and PB is 3.03

What is the 52 Week High and Low of Trident Texofab shares?

Trident Texofab stock price high: Rs.76.1 Trident Texofab stock price low: Rs.45.75